Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
Legacy MEDSearch
OCTOBER 2, 2023
Food and Drug Administration (FDA) has approved the EMPAVELI Injector (enFuse ® ) for the subcutaneous delivery of EMPAVELI ® (pegcetacoplan), which is commercialized in the United States by Apellis Pharmaceuticals, Inc. Food and Drug Administration (FDA) Approval appeared first on Legacy MedSearch | Medical Device Recruiters.
Let's personalize your content